Prostaglandin E2 affects proliferation and collagen synthesis by human patellar tendon fibroblasts

Clinical Journal of Sport Medicine

Volumn 14, Issue 4, 2004, Pages 232-236

  Cilli, Feridun ^a   Khan, Mustafa ^a   Fu, Freddie ^a   Wang, James H C ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Collagen production; Proliferation; Prostaglandin E2; Tendon fibroblasts

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; COLLAGEN; PROSTAGLANDIN E2;

ADULT; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; DOSE RESPONSE; EXERCISE; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; PATELLA TENDON; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; STATISTICAL SIGNIFICANCE; TENDON DISEASE; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; KNEE; METABOLISM; REFERENCE VALUE; TENDON;

CELLS, CULTURED; COLLAGEN; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; KNEE JOINT; REFERENCE VALUES; TENDONS;

EID: 3342967455     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042752-200407000-00006     Document Type: Article

References (26)

1. Astrom M, Rausing A. Chronic Achilles tendinopathy: a survey of surgical and histopathologic findings. Clin Orthop. 1995; 316:151-164.
2. Archambault J, Wiley J, Bray R. Exercise loading of tendons and development of overuse injuries. Sports Med. 1995;20:77-89.
3. Khan KM, Maffulli N. Tendinopathy: an Achilles' heel for athletes and clinicians. Clin J Sport Med. 1998;8:151-154.
4. Almekinders LC, Banes AJ, Ballenger CA. Effects of repetitive motion on human fibroblasts. Med Sci Sports Exerc. 1993;25:603-607.
5. Wang JH, Jia F, Yang G, et al. Cyclic mechanical stretching of human tendon fibroblasts increases the production of prostaglandin E2 and levels of cyclooxygenase expression: a novel in vitro model study. Connect Tissue Res. 2003;44:128-133.
6. Langberg H, Skovgaard D, Karamouzis M, et al. Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis during intermittent isometric exercise in humans. J Physiol. 1999;515: 919-927.
7. Kuehl F, Egan R. Prostaglandins, arachidonic acid and inflammation. Science. 1980;210:978-984.
8. Davies P, Bailey PJ, Goldenberg MM, et al. The role of arachidonic acid oxygenation products in pain and inflammation. Annu Rev Immunol. 1984;2:335-357.
9. Bombardieri S, Cattani P, Ciabattoni G, et al. The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs. Br J Pharmacol. 1981;73:893-901.
10. Fine A, Poliks CF, Donahue LP, et al. The differential effect of prostaglandin E2 on transforming growth factor-beta and insulin-induced collagen formation in lung fibroblasts. J Biol Chem. 1989;264:16988-16991.
11. Diaz A, Varga J, Jimenez SA. Transforming growth factor-beta stimulation of lung fibroblast prostaglandin E2 production. J Biol Chem. 1989; 264:11554-11557.
12. Voytik-Harbin SL, Brightman AO, Waisner B, et al. Application and evaluation of the alamarBlue assay for cell growth and survival of fibroblasts. In Vitro Cell Dev Biol Anim. 1998;34:239-246.
13. Baud L, Perez J, Denis M, et al. Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. J Immunol. 1987; 138:1190-1195.
14. Bitterman PB, Wewers MD, Rennard SI, et al. Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J Clin Invest. 1986;77:700-708.
15. Elias JA, Zurier RB, Schreiber AD, et al. Monocyte inhibition of lung fibroblast growth: relationship to fibroblast prostaglandin production and density-defined monocyte subpopulations. J Leukoc Biol. 1985;37: 15-28.
16. Fine A, Goldstein R. The effect of PGE2 on the activation of quiescent lung fibroblasts. Prostaglandins. 1987;33:903-913.
17. Austin SC, Funk CD. Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions. Prostaglandins Other Lipid Mediat. 1999;58:231-252.
18. Breyer MD, Jacobson HR, Breyer RM. Functional and molecular aspects of renal prostaglandin receptors. J Am Soc Nephrol. 1996;7:8-17.
19. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev. 1994;46: 205-229.
20. Barile FA, Ripley-Rouzier C, Siddiqi ZE, et al. Effects of prostaglandin E1 on collagen production and degradation in human fetal lung fibroblasts. Arch Biochem Biophys. 1988;265:441-446.
21. Diaz A, Munoz E, Johnston R, et al. Regulation of human lung fibroblast alpha 1 (I) procollagen gene expression by tumor necrosis factor alpha, interleukin-1 beta, and prostaglandin E2. J Biol Chem. 1993;268:10364-10371.
22. Gallagher A, Yu H, Printz M. Bradykinin-induced reductions in collagen gene expression involve prostacyclin. Hypertension. 1998;32:84-88.
23. Almekinders LC, Baynes AJ, Bracey LW. An in vitro investigation into the effects of repetitive motion and nonsteroidal antiinflammatory medication on human tendon fibroblasts. Am J Sports Med. 1995;23:119-123.
24. Khan KM, Cook JL, Kannus P, et al. Time to abandon the "tendinitis" myth. BMJ. 2002;324:626-627.
25. Riley G. The pathogenesis of tendinopathy: a molecular perspective. Rheumatology (Oxford) 2004;43:131-142.
26. Astrom M, Rausing A. Chronic Achilles tendinopathy: a survey of surgical and histopathologic findings. Clin Orthop. 1995;316:151-164.